TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PLYX

Polaryx Therapeutics, Inc.

Healthcare · Biotechnology

2.00$ -4.3% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLYX
Line item Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– 100.0% 100.0% 100.0% 100.0% 95.4% 100.0% 100.0%
– 92.4% 93.8% 93.3% 96.0% 94.9% 87.9% 97.7%
– 92.4% 93.8% 93.3% 96.0% 94.9% 87.9% 97.7%
– 5.8% 4.2% 8.4% 11.4% 15.8% 29.0% 7.4%
– 5.8% 4.2% 8.4% 11.4% 11.2% 29.0% 7.4%
– 1.4% 1.2% 4.5% 8.3% 8.7% 24.3% 5.8%
– 94.2% 95.8% 91.6% 88.6% 84.2% 71.0% 92.6%
– -1,812.6% -2,156.5% -2,729.6% -1,640.3% -1,838.3% -2,917.7% -876.7%
– 3,786.7% 4,267.1% 5,345.0% 3,165.2% 873.5% 1,348.4% 408.7%

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?